Primary total hip arthroplasty and total knee arthroplasty are safe and effective procedures for patients with end-stage osteoarthritis^[@R1]^. New techniques and technologies have been developed to improve the outcomes of total hip arthroplasty and total knee arthroplasty, including renewed interest in the direct anterior hip approach^[@R2]^, dual-mobility hip implants^[@R3]^, patient-specific instrumentation and implants^[@R4]^, and robotic and computer-assisted navigation^[@R5]-[@R8]^. While such technologies may potentially improve outcomes, they add expense to these procedures. As health-care costs continue to rise, an emphasis on value-based care necessitates that new technologies be considered not only for their clinical effectiveness but also for their cost effectiveness^[@R9]^.

The quality-adjusted life year (QALY) is the preferred outcome measurement for cost-effectiveness analysis in health care according to the U.S. Panel on Cost-Effectiveness in Health and Medicine^[@R10]^. QALYs are a generic measurement of health-related quality of life as defined on a 0 to 1 scale; a year of perfect health is worth 1 QALY, and a year of less-than-perfect health is worth \<1. QALYs are a measure of patient utility and can be determined with use of the EuroQol 5-Dimension (EQ-5D), Short Form 6-Dimension (SF-6D), and Health Utility Index (HUI) questionnaires^[@R11]^.

To our knowledge, no recent studies have comprehensively provided patient utility outcomes after both primary and revision hip and knee arthroplasty. Several studies have provided information on QALY gains after primary total hip arthroplasty^[@R12]-[@R15]^ and primary total knee arthroplasty^[@R13],[@R14],[@R16]^. However, those studies included small numbers of patients and did not delineate QALY outcomes after numerous other hip and knee reconstruction procedures such as revision surgery, hip resurfacing, and partial knee arthroplasty. Furthermore, it is not known what factors predict the changes in patient utility after joint replacement.

The goal of the present study was to comprehensively determine patient health-related quality of life after hip and knee replacement as assessed with the EQ-5D and SF-6D instruments. For hip arthroplasty, we examined primary total hip arthroplasty, hip resurfacing, aseptic revision total hip arthroplasty, septic revision total hip arthroplasty, conversion of prior hemiarthroplasty to total hip arthroplasty, and conversion of prior hip resurfacing to total hip arthroplasty. For knee arthroplasty, we examined primary total knee arthroplasty, medial unicompartmental knee arthroplasty, aseptic revision total knee arthroplasty, septic revision total knee arthroplasty, conversion of unicompartmental knee arthroplasty to total knee arthroplasty, and patellofemoral replacement. Furthermore, we examined patient-related factors that predict the gain in patient utility after joint replacement.

Materials and Methods {#s1}
=====================

Patients {#s1-1}
--------

We conducted a retrospective review of patients who had been prospectively enrolled in our institution's institutional review board-approved joint database from May 2007 to December 2011. The present study included all patients who had available preoperative and 2-year postoperative EQ-5D, SF-36, or SF-12 data who had undergone primary total hip arthroplasty, hip resurfacing, aseptic revision total hip arthroplasty, septic revision total hip arthroplasty, conversion of prior hemiarthroplasty to total hip arthroplasty, conversion of prior hip resurfacing to total hip arthroplasty, primary total knee arthroplasty, medial unicompartmental knee arthroplasty, aseptic revision total knee arthroplasty, septic revision total knee arthroplasty, conversion of unicompartmental knee arthroplasty to total knee arthroplasty, or patellofemoral replacement. Age, sex, body mass index (BMI), the Charlson Comorbidity Index (CCI), the American Society of Anesthesiologists (ASA) score, and the preoperative diagnosis were recorded for each patient. The patient characteristics for select procedures are summarized in Table I. Patients were excluded if no scores were available for any of the 3 instruments (EQ-5D, SF-36, and SF-12).

###### 

Patient Characteristics for Hip and Knee Procedures[\*](#tblfn1){ref-type="table-fn"}

                                                         Hip                                                                                 Knee                                                                                                                                                                                                                                                                               
  ------------------------------------------------------ ----------------------------------------------------------------------------------- ------------------------------------------------------------------------------- ----------------------------- ------------------------------------------------------------------------------------- ------------------------------------------------------------------------------ -----------------------------
  No. of patients[†](#tblfn2){ref-type="table-fn"}       5,463                                                                               843                                                                             440                           5,398                                                                                 240                                                                            323
  Age[‡](#tblfn3){ref-type="table-fn"} *(yr)*            64.2 ± 11.5                                                                         51.2 ± 7.6                                                                      66.4 ± 12.3                   66.9 ± 9.5                                                                            63.7 ± 10.2                                                                    65.3 ± 10.7
  Sex                                                    55.6% female, 44.4% male                                                            21.5% female, 78.5% male                                                        50.0% female, 50.0% male      61.2% female, 38.8% male                                                              60.4% female, 39.6% male                                                       48.3% female, 51.7% male
  BMI[‡](#tblfn3){ref-type="table-fn"} *(kg/m*^*2*^*)*   27.7 ± 5.5                                                                          27.3 ± 4.4                                                                      27.3 ± 5.4                    30.1 ± 6.1                                                                            28.8 ± 4.9                                                                     30.3 ± 6.2
  CCI[‡](#tblfn3){ref-type="table-fn"}                   0.36 ± 0.92                                                                         0.12 ± 0.47                                                                     0.46 ± 0.97                   0.44 ± 0.95                                                                           0.4 ± 0.84                                                                     0.48 ± 0.83
  ASA score[§](#tblfn4){ref-type="table-fn"}                                                                                                                                                                                                                                                                                                                                                                                    
   1 or 2                                                4,496 (82.3%)                                                                       816 (96.8%)                                                                     310 (70.5%)                   4,280 (79.3%)                                                                         208 (86.7%)                                                                    234 (72.4%)
   3 or 4                                                967 (17.7%)                                                                         27 (3.2%)                                                                       130 (29.5%)                   1,118 (20.7%)                                                                         32 (13.3%)                                                                     89 (27.6%)
  Diagnosis[\#](#tblfn5){ref-type="table-fn"}            Osteoarthritis (5,163; 94.5%), inflammatory arthritis (54; 1%), other (246; 4.5%)   Osteoarthritis (816; 96.8%), inflammatory arthritis (1; 0.1%), other (25; 3%)   Aseptic failure (440; 100%)   Osteoarthritis (5,192; 96.2%), inflammatory arthritis (64; 1.2%), other (142; 2.6%)   Osteoarthritis (231; 96.3%), inflammatory arthritis (0; 0%), other (9; 3.8%)   Aseptic failure (323; 100%)

BMI = body mass index, CCI = Charlson Comorbidity Index, and ASA = American Society of Anesthesiologists.

Number of patients with preoperative EQ-5D, SF-36, and/or SF-12 scores available.

The values are given as the mean and the standard deviation.

The values are given as the number of patients, with the percentage in parentheses.

The number and percentage of patients with each diagnosis are shown in parentheses.

EQ-5D {#s1-2}
-----

The EQ-5D health questionnaire^[@R17]^ includes 5 domains: mobility, self-care, usual activities, pain or discomfort, and anxiety or depression. Responses have 3 levels of severity, ranging from no problems to extreme problems. This instrument allows for 243 health states, which are correlated with utility values from a sample United States population with use of time-tradeoff methods. The utility values for each health state are scored between 0 and 1.

SF-6D {#s1-3}
-----

The SF-6D utility score, which is derived from the SF-36 and SF-12 scoring systems, includes 6 categories: vitality, pain, mental health, social functioning, physical functioning, and role limitations. Each category is scored by severity level. Different answers produce a large number of possible health states. Each health state is correlated with an index utility score of between 0 and 1, with 0 representing death and 1 representing full health, by applying a weighting specific for the United States that is based on a standard gamble technique^[@R11]^. All SF-36 or SF-12 scores were converted into SF-6D index scores.

Statistical Analysis {#s1-4}
--------------------

For all procedures with available data for \>100 patients, we utilized multivariate linear regression to analyze the effect of patient-related factors on the predicted change in QALYs from the preoperative baseline to 2 years postoperatively. These procedures included primary total hip arthroplasty, hip resurfacing, aseptic revision total hip arthroplasty, primary total knee arthroplasty, unicompartmental knee arthroplasty, and aseptic revision total knee arthroplasty. Explanatory variables were patient age, sex, BMI, ASA score, CCI, preoperative utility, and diagnosis.

Results {#s2}
=======

Six thousand, seven hundred and eighty-six patients were analyzed after hip arthroplasty procedures, including primary total hip arthroplasty (5,463 patients; 80.5%), hip resurfacing (843 patients; 12.4%), aseptic revision total hip arthroplasty (440 patients; 6.5%), septic revision total hip arthroplasty (4 patients; 0.06%), conversion of hemiarthroplasty to total hip arthroplasty (24 patients; 0.4%), and conversion of hip resurfacing to total hip arthroplasty (12 patients; 0.2%). Five thousand, nine hundred and ninety-six patients underwent knee arthroplasty procedures, including primary total knee arthroplasty (5,398 patients; 90.0%), medial unicompartmental knee arthroplasty (240 patients; 4.0%), aseptic revision total knee arthroplasty (323 patients; 5.4%), septic revision total knee arthroplasty (6 patients; 0.1%), conversion of prior unicompartmental knee arthroplasty to total knee arthroplasty (15 patients; 0.25%), and patellofemoral replacement (14 patients; 0.23%). Patient characteristics by procedure are summarized in Table I. Annual gain in QALYs after surgery are summarized in Figures [1](#F1a){ref-type="fig"}-A through [2](#F2c){ref-type="fig"}-C.

###### 

**Figs. 1-A, 1-B, and 1-C** Changes in annual QALYs (as measured with the EQ-5D questionnaire) 2 years after hip procedures. The blue bars represent QALY gains, and the red bars represent QALY losses.

![QALY gains and losses after total hip arthroplasty.](jbjsoa-3-e0007-g001){#F1a}

![QALY gains and losses after hip resurfacing.](jbjsoa-3-e0007-g002){#F1b}

![QALY Gains and losses after aseptic revision total hip arthroplasty.](jbjsoa-3-e0007-g003){#F1c}

###### 

**Figs. 2-A, 2-B, and 2-C** Changes in annual QALYs (as measured with the EQ-5D questionnaire) 2 years after knee procedures. The green bars represent QALY gains, and the red bars represent QALY losses.

![QALY gains and losses after total knee arthroplasty.](jbjsoa-3-e0007-g004){#F2a}

![QALY gains and losses after medial unicompartmental knee arthroplasty.](jbjsoa-3-e0007-g005){#F2b}

![QALY gains and losses after aseptic revision total knee arthroplasty.](jbjsoa-3-e0007-g006){#F2c}

Primary Total Hip Arthroplasty {#s2-1}
------------------------------

Table II summarizes the change in utility after hip arthroplasty. Three thousand, four hundred and fifty-three patients who underwent primary total hip arthroplasty had a mean 2-year postoperative increase in the EQ-5D score (and standard deviation) of 0.25 ± 0.2. Four thousand, eight hundred and thirty-four patients who underwent primary total hip arthroplasty had a 2-year postoperative increase in the SF-6D score of 0.18 ± 0.13. Three thousand, six hundred and one patients who underwent primary total hip arthroplasty had a 5-year postoperative increase in the SF-6D score of 0.2 ± 0.13. For primary total hip arthroplasty, the variables of age, sex, BMI, ASA score, and preoperative utility as measured with the EQ-5D index were all significant predictors of annual QALY gain (p \< 0.0001 for all) and collectively predicted 58.8% of the variation in patient outcomes (Table III). Higher age, BMI, ASA score, and CCI were all associated with a slightly lower QALY gain. A moderately higher QALY gain was associated with male sex. The strongest predictor of QALY gain was a lower baseline preoperative quality of life; the lower the preoperative annual QALY, the higher the expected postoperative QALY gain.

###### 

Utility Changes After Hip Arthroplasty Procedures

                                                             EQ-5D         SF-6D                                                                                                                
  ---------------------------------------------------------- ------------- ------------- ---------- ------------- ------------- ------------- ---------- ------------- ---------- ------------- -------------
  Primary total hip arthroplasty                                                                                                                                                                
   No. of patients                                           5,353         3,514                    3,453         5,154         5,076                    3,785                    4,834         3,601
   Score[\*](#tblfn6){ref-type="table-fn"}                   0.63 ± 0.19   0.88 ± 0.14   \<0.0001   0.25 ± 0.20   0.6 ± 0.11    0.79 ± 0.13   \<0.0001   0.81 ± 0.13   \<0.0001   0.18 ± 0.13   0.2 ± 0.13
  Hip resurfacing                                                                                                                                                                               
   No. of patients                                           829           576                      566           807           814                      637                      782           611
   Score[\*](#tblfn6){ref-type="table-fn"}                   0.68 ± 0.16   0.93 ± 0.11   \<0.0001   0.24 ± 0.17   0.63 ±0.10    0.82 ± 0.12   \<0.0001   0.84 ± 0.12   \<0.0001   0.19 ± 0.13   0.21 ± 0.12
  Aseptic revision total hip arthroplasty                                                                                                                                                       
   No. of patients                                           434           292                      287           411           399                      268                      380           254
   Score[\*](#tblfn6){ref-type="table-fn"}                   0.63 ± 0.22   0.8 ± 0.17    \<0.0001   0.17 ± 0.23   0.6 ± 0.12    0.72 ± 0.14   \<0.0001   0.74 ± 0.15   \<0.0001   0.12 ± 0.14   0.14 ± 0.15
  Septic revision total hip arthroplasty                                                                                                                                                        
   No. of patients                                           3             4                        3             3             3                        2                        2             1
   Score[\*](#tblfn6){ref-type="table-fn"}                   0.58 ± 0.35   0.72 ± 0.19   0.52       0.13 ± 0.51   0.64 ± 0.03   0.69 ± 0.05   0.21       0.62 ± 0.05   0.60       0.04 ± 0.03   0.04
  Conversion of hemiarthroplasty to total hip arthroplasty                                                                                                                                      
   No. of patients                                           23            18                       17            23            24                       13                       23            13
   Score[\*](#tblfn6){ref-type="table-fn"}                   0.64 ± 0.15   0.78 ± 0.18   0.0098     0.13 ± 0.18   0.63 ± 0.11   0.71 ± 0.12   0.022      0.75 ± 0.13   0.0058     0.09 ± 0.1    0.09 ± 0.13
  Conversion of hip resurfacing to total hip arthroplasty                                                                                                                                       
   No. of patients                                           12            5                        5             11            12                       9                        11            8
   Score[\*](#tblfn6){ref-type="table-fn"}                   0.67 ± 0.18   0.93 ± 0.1    0.0089     0.18 ± 0.13   0.59 ± 0.10   0.74 ± 0.16   0.015      0.79 ± 0.17   0.0042     0.13 ± 0.13   0.16 ± 0.11

The scores are given as the mean and the standard deviation. The p values were determined with use of the Student t test.

###### 

Multiple Regression Analysis: Hip Arthroplasty[\*](#tblfn7){ref-type="table-fn"} [†](#tblfn8){ref-type="table-fn"}

                                               Primary Total Hip Arthroplasty   Hip Resurfacing   Aseptic Revision Total Hip Arthroplasty                               
  -------------------------------------------- -------------------------------- ----------------- ----------------------------------------- ---------- ---------------- ----------
  Intercept[‡](#tblfn9){ref-type="table-fn"}   0.898 ± 0.020                    \<0.0001          0.793 ± 0.044                             \<0.0001   0.605 ± 0.075    \<0.0001
  Age                                          −0.001 ± 0.0002                  \<0.00001         0.001 ± 0.001                             0.199      0.001 ± 0.001    0.485
  BMI                                          −0.002 ± 0.0004                  \<0.0001          −0.001 ± 0.001                            0.585      0.0002 ± 0.002   0.902
  CCI                                          −0.004 ± 0.002                   0.056             0.010 ± 0.009                             0.304      −0.005 ± 0.010   0.613
  Sex (male vs. female)                        0.025 ± 0.005                    \<0.0001          0.020 ± 0.011                             0.068      0.045 ± 0.019    0.021
  ASA score (3 or 4 vs. 1 or 2)                −0.030 ± 0.006                   \<0.0001          −0.081 ± 0.023                            0.001      −0.020 ± 0.023   0.374
  Preoperative EQ-5D index score               −0.812 ± 0.012                   \<0.0001          −0.860 ± 0.028                            \<0.0001   −0.771 ± 0.044   \<0.0001

The outcome variable was defined as the change from the baseline preoperative EQ-5D index score to the 2-year postoperative EQ-5D index score. BMI = body mass index, CCI = Charlson Comorbidity Index, and ASA = American Society of Anesthesiologists.

R^2^ = 0.588 for primary total hip arthroplasty, 0.639 for hip resurfacing, and 0.523 for aseptic revision total hip arthroplasty.

The intercept is the expected value when all of the values in the regression model are set to 0.

Hip Resurfacing {#s2-2}
---------------

Five hundred and sixty-six patients who underwent hip resurfacing had a 2-year postoperative increase in the EQ-5D score of 0.24 ± 0.17. Seven hundred and eighty-two patients who underwent hip resurfacing had a 2-year increase in the SF-6D score of 0.19 ± 0.13. Six hundred and eleven patients who underwent hip resurfacing had a 5-year increase in the SF-6D score of 0.21 ± 0.12. There were no statistically significant differences in annual QALY gain as measured with the EQ-5D or SF-6D index when primary total hip arthroplasty was compared with hip resurfacing (p = 0.638, p = 0.507). The ASA score (p = 0.001) and preoperative baseline utility scores as measured with the EQ-5D index (p \< 0.0001) were predictive of QALY gain after hip resurfacing; these 2 variables explained 63.9% of the variation in QALY gain (Table III). A lower preoperative utility score was associated with a higher postoperative annual QALY gain.

Aseptic Revision Total Hip Arthroplasty {#s2-3}
---------------------------------------

Two hundred and eighty-seven patients who underwent aseptic revision total hip arthroplasty had a 2-year postoperative increase in the EQ-5D score of 0.17 ± 0.23. This increase was significantly lower than the EQ-5D utility gained after primary total hip arthroplasty (p \< 0.0001). Three hundred and eighty patients who underwent aseptic revision total hip arthroplasty had a 2-year gain in the SF-6D score of 0.12 ± 0.14. Likewise, this increase was significantly lower than the SF-6D utility gained after primary total hip arthroplasty after 2 years (p \< 0.0001). Two hundred and fifty-four patients demonstrated a 5-year postoperative increase in the SF-6D score of 0.14 ± 0.15, which was also significantly lower than the corresponding 5-year outcome after primary total hip arthroplasty (p \< 0.0001). Patient sex (p = 0.021) and preoperative utility (p \< 0.0001) explained 52.3% of the variation in annual QALY gain after revision total hip arthroplasty (Table III).

Additional Hip Procedures {#s2-4}
-------------------------

Fewer patients had complete utility scores available after conversion of hemiarthroplasty to total hip arthroplasty (17 patients), conversion of hip resurfacing to total hip arthroplasty (5 patients), and septic revision total hip arthroplasty (3 patients). Utilities for these patients are summarized in Table II.

Primary Total Knee Arthroplasty {#s2-5}
-------------------------------

Table IV summarizes the change in utility after knee arthroplasty. Three thousand, three hundred and nine patients who underwent total knee arthroplasty had a 2-year postoperative increase in the ED-5D score of 0.17 ± 0.19. Four thousand, eight hundred and fifty-one patients who underwent primary total knee arthroplasty had a 2-year postoperative increase in the SF-6D score of 0.14 ± 0.13. Three thousand, three hundred and fifty-four patients who underwent primary total knee arthroplasty had a 5-year postoperative increase in the SF-6D score of 0.15 ± 0.13. Patient BMI, CCI, sex, ASA score, and preoperative baseline utility as measured with the EQ-5D index were all significant predictors of 2-year postoperative utility gain (Table V). Together, these factors explained 44.6% of the variation in utility gain after primary total knee arthroplasty. The strongest predictor of utility gain was preoperative baseline utility.

###### 

Utility Changes After Knee Arthroplasty Procedures

                                                                                EQ-5D         SF-6D                                                                                                                
  ----------------------------------------------------------------------------- ------------- ------------- ---------- ------------- ------------- ------------- ---------- ------------- ---------- ------------- -------------
  Primary total knee arthroplasty                                                                                                                                                                                  
   No. of patients                                                              5,282         3,379                    3,309         5,127         5,064                    3,509                    4,851         3,354
   Score[\*](#tblfn10){ref-type="table-fn"}                                     0.68 ± 0.17   0.84 ± 0.15   \<0.0001   0.17 ± 0.19   0.63 ± 0.11   0.76 ± 0.13   \<0.0001   0.79 ± 0.13   \<0.0001   0.14 ± 0.13   0.15 ± 0.13
  Unicompartmental knee arthroplasty                                                                                                                                                                               
   No. of patients                                                              235           160                      158           232           233                      162                      226           159
   Score[\*](#tblfn10){ref-type="table-fn"}                                     0.71 ± 0.14   0.87 ± 0.13   \<0.0001   0.16 ± 0.17   0.65 ± 0.11   0.8 ± 0.13    \<0.0001   0.8 ± 0.14    \<0.0001   0.15 ± 0.12   0.15 ± 0.12
  Aseptic revision total knee arthroplasty                                                                                                                                                                         
   No. of patients                                                              312           225                      217           301           307                      197                      288           186
   Score[\*](#tblfn10){ref-type="table-fn"}                                     0.61 ± 0.2    0.74 ± 0.18   \<0.0001   0.13 ± 0.21   0.59 ± 0.11   0.69 ± 0.14   \<0.0001   0.72 ± 0.14   \<0.0001   0.1 ± 0.13    0.13 ± 0.14
  Septic revision total knee arthroplasty                                                                                                                                                                          
   No. of patients                                                              6             5                        5             5             6                        2                        5             2
   Score[\*](#tblfn10){ref-type="table-fn"}                                     0.5 ± 0.3     0.71 ± 0.22   0.23       0.28 ± 0.21   0.51 ± 0.14   0.65 ± 0.16   0.16       0.69 ± 0.24   0.25       0.14 ± 0.12   0.15 ± 0.03
  Conversion of unicompartmental knee arthroplasty to total knee arthroplasty                                                                                                                                      
   No. of patients                                                              15            8                        8             15            15                       12                       15            12
   Score[\*](#tblfn10){ref-type="table-fn"}                                     0.69 ± 0.14   0.82 ± 0.08   0.025      0.08 ± 0.13   0.62 ± 0.1    0.71 ± 0.1    0.02       0.78 ± 0.14   0.002      0.09 ± 0.12   0.15 ± 0.16
  Patellofemoral arthroplasty                                                                                                                                                                                      
   No. of patients                                                              14            8                        8             14            14                       12                       14            12
   Score[\*](#tblfn10){ref-type="table-fn"}                                     0.66 ± 0.18   0.85 ± 0.1    0.013      0.08 ± 0.09   0.62 ± 0.09   0.76 ± 0.14   0.004      0.78 ± 0.1    0.0003     0.13 ± 0.15   0.14 ± 0.1
                                                                                                                                                                                                                   

The scores are given as the mean and the standard deviation. The p values were determined with use of the Student t test.

###### 

Multiple Regression Analysis: Knee Arthroplasty[\*](#tblfn11){ref-type="table-fn"}[†](#tblfn12){ref-type="table-fn"}

                                                Primary Total Knee Arthroplasty   Unicompartmental Knee Arthroplasty   Aseptic Revision Total Knee Arthroplasty                               
  --------------------------------------------- --------------------------------- ------------------------------------ ------------------------------------------ ---------- ---------------- ----------
  Intercept[‡](#tblfn13){ref-type="table-fn"}   0.749 ± 0.026                     \<0.0001                             0.695 ± 0.101                              \<0.0001   0.494 ± 0.096    \<0.0001
  Age                                           −0.001 ± 0.0003                   0.051                                0.000 ± 0.001                              0.986      0.003 ± 0.001    0.002
  BMI                                           −0.001 ± 0.0004                   0.008                                0.000 ± 0.002                              0.843      −0.004 ± 0.002   0.047
  CCI                                           −0.006 ± 0.003                    0.023                                0.012 ± 0.012                              0.341      −0.020 ± 0.013   0.115
  Sex (male vs. female)                         0.027 ± 0.005                     \<0.0001                             0.032 ± 0.021                              0.124      0.034 ± 0.022    0.126
  ASA score (3 or 4 vs. 1 or 2)                 −0.044 ± 0.006                    \<0.0001                             −0.022 ± 0.029                             0.440      −0.097 ± 0.025   0.0001
  Preoperative EQ-5D index score                −0.753 ± 0.015                    \<0.0001                             −0.802 ± 0.070                             \<0.0001   −0.718 ± 0.056   \<0.0001

The outcome variable was defined as the change from the baseline preoperative EQ-5D index score to the 2-year postoperative EQ-5D index score. BMI = body mass index, CCI = Charlson Comorbidity Index, and ASA = American Society of Anesthesiologists.

R^[@R2]^ = 0.446 for primary total knee arthroplasty, 0.467 for unicompartmental knee arthroplasty, and 0.454 for aseptic revision total knee arthroplasty.

The intercept is the expected value when all of the values in the regression model are set to 0.

Unicompartmental Knee Arthroplasty {#s2-6}
----------------------------------

One hundred and fifty-eight patients who underwent medial compartment unicompartmental knee arthroplasty had a mean 2-year increase in the ED-5D score of 0.16 ± 0.17; this increase was not significantly different from that following primary total knee arthroplasty (p = 0.814). Two hundred and twenty-six patients who underwent unicompartmental knee arthroplasty had a 2-year increase in the SF-6D score of 0.15 ± 0.12, whereas 159 patients demonstrated a 5-year increase of 0.15 ± 0.12. Neither value was statistically different from the corresponding value following primary total knee arthroplasty. Only preoperative baseline utility as measured by the EQ-5D index was predictive of 2-year utility gain after unicompartmental knee arthroplasty (p \< 0.0001); this factor explained 46.7% of the variability in the utility gain after surgery (Table V).

Aseptic Revision Total Knee Arthroplasty {#s2-7}
----------------------------------------

Two hundred and seventeen patients who underwent aseptic revision total knee arthroplasty had a 2-year increase in the EQ-5D score of 0.13 ± 0.21. Two hundred and eighty-eight patients had a 2-year increase in the SF-6D score of 0.1 ± 0.13, and 186 patients had a 5-year increase in the SF-6D score of 0.13 ± 0.14. In all cases, postoperative utility gain was significantly lower after aseptic revision total knee arthroplasty than after primary total knee arthroplasty (p \< 0.0001). Age, BMI, ASA score, and preoperative utility as measured by the EQ-5D index were all significant predictors of 2-year utility gain after aseptic revision total knee arthroplasty; these factors explained 45.4% of the variation in utility gain after aseptic revision total knee arthroplasty (Table V).

Additional Knee Procedures {#s2-8}
--------------------------

Fewer patients had complete utility scores available after conversion of unicompartmental knee arthroplasty to total knee arthroplasty (8 patients), patellofemoral replacement (8 patients), and septic revision total knee arthroplasty (5 patients). Utilities associated with these procedures are summarized in Table IV.

Discussion {#s3}
==========

The present study summarizes preoperative and postoperative health-related quality of life in terms of annual QALYs gained after hip and knee arthroplasty. Our results demonstrated that hip and knee osteoarthritis had a negative impact on health-related quality of life comparable to that of major medical conditions^[@R18]-[@R21]^ (Table VI). Both hip and knee arthroplasty resulted in a large increase in quality of life as measured in QALYs with use of either the EQ-5D or the SF-6D instrument. After primary arthroplasty, the average patient health-related quality of life was similar to values in the literature for healthy patients without osteoarthritis (Table VI).

###### 

Comparison of Health-Related Quality of Life for Different Health States

  Health State                                                                    QALY    Source
  ------------------------------------------------------------------------------- ------- ----------------------------------------
  Healthy, age 55-59 yr                                                           0.906   Kwon et al.^[@R19]^ (2016)
  Healthy, age 60-64 yr                                                           0.885   Kwon et al.^[@R19]^ (2016)
  Healthy, age 65-69 yr                                                           0.837   Kwon et al.^[@R19]^ (2016)
  Healthy, age 70-74 yr                                                           0.807   Kwon et al.^[@R19]^ (2016)
  5 yr after primary total hip arthroplasty[\*](#tblfn14){ref-type="table-fn"}    0.81    Current study
  5 yr after primary total knee arthroplasty[\*](#tblfn14){ref-type="table-fn"}   0.79    Current study
  Minor stroke                                                                    0.73    Luengo-Fernandez et al.^[@R18]^ (2013)
  Venous thromboembolism                                                          0.697   Kwon et al.^[@R19]^ (2016)
  Knee osteoarthritis[\*](#tblfn14){ref-type="table-fn"}                          0.63    Current study
  Hip osteoarthritis[\*](#tblfn14){ref-type="table-fn"}                           0.6     Current study
  Acute myocardial infarction                                                     0.54    Soto et al.^[@R20]^ (2016)
  Hip fracture                                                                    0.535   Kwon et al.^[@R19]^ (2016)
  Moderate stroke                                                                 0.56    Luengo-Fernandez et al.^[@R18]^ (2013)
  Metastatic lung cancer                                                          0.53    Doble et al.^[@R21]^ (2017)
  Severe stroke                                                                   0.38    Luengo-Fernandez et al.^[@R18]^ (2013)

Values reported with use of the SF-6D.

We found no differences in annual QALY gain between primary total hip arthroplasty and hip resurfacing. Similarly, we found no difference between utility gain after primary total knee arthroplasty and unicompartmental knee arthroplasty. Total hip arthroplasty resulted in greater utility gain than total knee arthroplasty. Revision hip and knee replacement resulted in a positive gain in annual QALYs, although the gain was lower than that after primary surgery.

We observed considerable variation in quality-of-life outcomes. Higher preoperative QALYs were consistently the strongest negative predictor of postoperative QALY gain after total hip arthroplasty, hip resurfacing, aseptic revision total hip arthroplasty, total knee arthroplasty, unicompartmental knee arthroplasty, and aseptic revision total knee arthroplasty. This finding is intuitive: patients who have the lowest preoperative quality of life will potentially benefit the most from surgical intervention, whereas those with mild symptoms can expect small or even negative changes in their quality of life.

Recently reported utility gains after primary total hip arthroplasty have ranged from 0.166 to 0.358 (Table VII)^[@R12]-[@R15]^. For total hip arthroplasty, our study demonstrated an annual QALY gain of 0.25 for 3,453 patients with use of the EQ-5D index and a gain of 0.18 for 4,834 patients with use of the SF-6D index. Utility changes after primary total knee arthroplasty also have been described^[@R13],[@R14],[@R16]^, with gains ranging from 0.125 to 0.267 (Table VIII). For primary total knee arthroplasty, we found an annual QALY gain of 0.17 for 3,309 patients with use of the EQ-5D index and a gain of 0.14 for 4,851 patients with use of the SF-6D index. Whereas the aforementioned studies involved the use of either the EQ-5D or the SF-6D index, our study involved the use of both instruments to determine utility gain. To our knowledge, the present report describes the largest study on QALY changes after primary hip and knee replacements in the United States. Additionally, to our knowledge, our study provides the first recent report on utility outcomes after hip resurfacings, unicompartmental knee replacements, and aseptic revision hip and knee replacements in a large number of patients.

###### 

Comparison of Quality-of-Life Changes After Primary Total Hip Arthroplasty[\*](#tblfn15){ref-type="table-fn"}

                                                            Preop.   2-Yr Postop.                                                           
  -------------------------------- ---------------- ------- -------- --------------- -------------------------------------- --------------- -------
  Elmallah et al.^[@R12]^ (2017)   United States    SF-6D   194      0.614 ± 0.131   182                                    0.77 ± 0.14     0.185
  Liebs et al.^[@R13]^ (2016)                                                                                                               
   Early aquatic cohort            Germany          SF-6D   129      0.556 ± 0.098   100                                    0.73 ± 0.146    0.164
   Late aquatic cohort             Germany          SF-6D   141      0.554 ± 0.105   110                                    0.744 ± 0.122   0.181
  Jenkins et al.^[@R14]^ (2013)    United Kingdom   EQ-5D   348      0.323 ± 0.32    NR[†](#tblfn16){ref-type="table-fn"}   0.721 ± 0.255   0.358
  Fordham et al.^[@R15]^ (2012)    United Kingdom   SF-6D   938      0.537 ± 0.113   728                                    0.709 ± 0.159   0.166
  Current study                                                                                                                             
   EQ-5D cohort                    United States    EQ-5D   5,353    0.63 ± 0.19     3,453                                  0.88 ± 0.14     0.25
   SF-6D cohort                    United States    SF-6D   5,154    0.68 ± 0.17     4,834                                  0.79 ± 0.13     0.18

QALY changes after total hip replacement in the current study as compared with recent studies.

NR = not reported.

###### 

Comparison of Quality-of-Life Changes After Primary Total Knee Arthroplasty[\*](#tblfn17){ref-type="table-fn"}

                                                                                              Preop.   2-Yr. Postop.                           
  ------------------------------------------------------------------ ---------------- ------- -------- --------------- ------- --------------- -------
  Elmallah et al.^[@R16]^ (2015)[†](#tblfn18){ref-type="table-fn"}   United States    SF-6D   844      0.62 ± NR‡      844     0.77 ± NR‡      0.15
  Liebs et al.^[@R13]^ (2016)                                                                                                                  
   Early aquatic cohort                                              Germany          SF-6D   87       0.581 ± 0.095   66      0.721 ± 0.119   0.125
   Late aquatic cohort                                               Germany          SF-6D   98       0.569 ± 0.101   69      0.703 ± 0.135   0.129
  Jenkins et al.^[@R14]^ (2013)                                      United Kingdom   EQ-5D   323      0.377 ± 0.312   NR‡     0.671 ± 0.268   0.267
  Current study                                                                                                                                
   EQ-5D cohort                                                      United States    EQ-5D   5,282    0.68 ± 0.17     3,309   0.84 ± 0.15     0.17
   SF-6D cohort                                                      United States    SF-6D   5,127    0.63 ± 0.11     4,851   0.76 ± 0.13     0.14

QALY changes after total knee replacement in the current study as compared with recent studies.

Study had 3-year follow-up. ‡NR = not reported.

To our knowledge, no prior study has systematically identified characteristics that predict QALY gain after hip and knee arthroplasty. We found that age, BMI, ASA score, sex, and preoperative utility correlated with QALY outcomes after primary total hip arthroplasty and total knee arthroplasty. These factors predicted 59% of the variation of patient outcomes following primary total hip arthroplasty and 45% of the variation in outcomes following primary total knee arthroplasty. These findings imply that patient selection is strongly predictive of postoperative QALY gain. Interestingly, age was a slight negative predictor of QALY gain. This finding may be due to decreased overall quality of life due to age^[@R22]^ as opposed to worse outcomes in elderly patients.

Preoperative health-related quality of life was the strongest predictor of QALY gain after hip and knee arthroplasty, including aseptic revision surgery. The lower the preoperative utility, the higher the expected QALY gain. This relationship was statistically significant and clinically important. For instance, our regression model (Table III) predicts that a patient with a preoperative utility of 0.55 would gain 0.33 QALY annually after total hip replacement; in contrast, a similar patient with a preoperative utility of 0.8 would gain only 0.125 QALY annually. Patients with the most compromised preoperative function gain the greatest postoperative improvement.

The present study had several limitations. Although QALYs are the preferred outcome measurement for economic analysis, they represent generic health outcomes. Therefore, patient-related health factors besides arthroplasty may affect postoperative QALYs. However, QALY outcomes are known to correlate with hip and knee-specific outcome instruments^[@R12],[@R16]^. Also, we were unable to exclude patients with postoperative complications, which may have negatively biased the results. Furthermore, we only had data on patients who had preoperative EQ-5D, SF-36, or SF-12 scores; we did not have information on patients who failed to answer preoperative questionnaires and therefore we were unable to calculate overall loss to follow-up. Additionally, for several procedures---including septic revisions, conversion of hemiarthroplasty or hip resurfacings to total hip arthroplasty, conversions of unicompartmental knee arthroplasty to total knee arthroplasty, and patellofemoral arthroplasties---we provided QALY outcomes for only a limited number of patients. However, we are aware of no previous studies that have provided such data for these procedures. Furthermore, fewer patients completed postoperative EQ-5D forms compared with SF-36 or SF-12 forms. However, as most patients completed other health questionnaires that provided similar results, we believe that this limitation did not strongly bias our results. Finally, we examined a high-volume arthroplasty center, and therefore our results may not be generalizable to institutions that perform fewer cases per year^[@R23]^.

In summary, we have provided preoperative and postoperative annual QALY results for common hip and knee arthroplasty procedures; many of these data were not previously available. We used both the EQ-5D and the SF-6D as the basis for our QALY estimates. Our results demonstrated that average health-related quality of life after primary hip or knee replacement approach those for healthy patients of similar age as reported in the recent literature. We delineated several patient-related factors that were associated with outcomes. While age, BMI, and ASA score were significant predictors, the most important factor for predicting annual QALY gains after hip and knee arthroplasty was the patient's preoperative quality of life: a lower preoperative utility was found to be highly predictive of larger QALY gains postoperatively. Our results may be used to facilitate future cost-effectiveness studies in arthroplasty, to counsel patients regarding expected outcomes, and to assist in selecting patients who may benefit most from arthroplasty.
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